Ramelteon and Clonidine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ramelteon (ramelteon) and Clonidine (clonidine). Common drug interactions include diarrhoea among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Ramelteon and Clonidine. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Ramelteon?

Ramelteon has active ingredients of ramelteon. It is often used in insomnia. eHealthMe is studying from 1,387 Ramelteon users. Check the latest studies of Ramelteon.

What is Clonidine?

Clonidine has active ingredients of clonidine. It is often used in high blood pressure. eHealthMe is studying from 65,644 Clonidine users. Check the latest studies of Clonidine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 14, 2026

20 people who take Ramelteon and Clonidine together, and have interactions are studied.

Ramelteon and Clonidine drug interactions.

What are the common drug interactions of Ramelteon and Clonidine, by gender? *:

female:

  1. Diarrhoea
  2. Blood pressure decreased
  3. Chronic kidney disease
  4. Complex regional pain syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet))
  5. Death
  6. Feeling hot
  7. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  8. Hyperhidrosis (abnormally increased sweating)
  9. Influenza
  10. Irritability

male:

  1. Chronic kidney disease
  2. Acidosis (build-up of carbon dioxide in the blood)
  3. Hyperhidrosis (abnormally increased sweating)
  4. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Renal tubular necrosis (death of kidney tubules)
  7. Sensory disturbance (sense disturbance)
  8. Temperature regulation disorder (body is unable to maintain temperature)
  9. Drug ineffective
  10. Hypokalaemia (low potassium)

What are the common drug interactions of Ramelteon and Clonidine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Diarrhoea
  2. Blood pressure decreased
  3. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  4. Influenza
  5. Irritability
  6. Retching (strong involuntary effort to vomit)
  7. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  8. Vomiting

10-19:

  1. Drug ineffective

20-29:

  1. Drooling (drop saliva uncontrollably from the mouth)

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)

50-59:

n/a

60+:

  1. Acidosis (build-up of carbon dioxide in the blood)
  2. Chronic kidney disease
  3. Diarrhoea
  4. Feeling hot
  5. Myalgia (muscle pain)
  6. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  7. Renal tubular necrosis (death of kidney tubules)
  8. Rhinorrhoea (watery mucus discharge from the nose)
  9. Sensory disturbance (sense disturbance)
  10. Temperature regulation disorder (body is unable to maintain temperature)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 20.00%
  2. Tardive Dyskinesia (a disorder that involves involuntary movements): 2 people, 10.00%
  3. Aggression: 2 people, 10.00%
  4. Sleep Disorder: 1 person, 5.00%
  5. Scoliosis (a medical condition in which a person's spine is curved from side to side): 1 person, 5.00%
  6. Renal Disorder (kidney disease): 1 person, 5.00%
  7. Multiple Myeloma (cancer of the plasma cells): 1 person, 5.00%
  8. Mood Swings (an extreme or rapid change in mood): 1 person, 5.00%
  9. Irregular Sleep Phase: 1 person, 5.00%
  10. Stress And Anxiety: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ramelteon and Clonidine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ramelteon and Clonidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ramelteon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Clonidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ramelteon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clonidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ramelteon and clonidine (the active ingredients of Ramelteon and Clonidine, respectively), and Ramelteon and Clonidine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: